Novartis AG (NVSEF)
USD 98.67
(0.0%)
USD 98.67
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.45 Billion | 14.23 Billion | 15.07 Billion | 13.65 Billion | 13.62 Billion | 14.27 Billion |
| Net Income | 8.57 Billion | 6.95 Billion | 24.01 Billion | 8.07 Billion | 7.14 Billion | 12.61 Billion |
| Depreciation & Amortization | 8.27 Billion | 7.18 Billion | 6.11 Billion | 6.46 Billion | 5.82 Billion | 6.89 Billion |
| Deferred income taxes | 551 Million | 1.41 Billion | 2.11 Billion | 1.8 Billion | 1.79 Billion | 1.22 Billion |
| Stock-based compensation | 865 Million | 791 Million | 700 Million | 738 Million | 758 Million | 759 Million |
| Change in working capital | -369 Million | -1 Billion | 241 Million | -291 Million | 199 Million | 499 Million |
| Other non-cash items | -3.43 Billion | -1.13 Billion | -18.15 Billion | -3.13 Billion | -2.09 Billion | -7.71 Billion |
| Investing Cash Flow | 5.59 Billion | 1.46 Billion | 4.2 Billion | -13.18 Billion | -2.22 Billion | -5.59 Billion |
| Investments in PPE | -2.75 Billion | -2.67 Billion | -2.97 Billion | -2.58 Billion | -2.25 Billion | -3.35 Billion |
| Acquisitions | -3.56 Billion | -903 Million | 20.1 Billion | -9.96 Billion | -3.76 Billion | -1.06 Billion |
| Investment purchases | -747 Million | -34.81 Billion | -16.59 Billion | -2.13 Billion | -530 Million | -2.7 Billion |
| Sales/Maturities of investments | 11.59 Billion | 39.49 Billion | 2.74 Billion | 1.21 Billion | 3.71 Billion | 639 Million |
| Other Investing Activities | 1.06 Billion | 368 Million | 931 Million | 282 Million | 614 Million | 895 Million |
| Financing Cash Flow | -14.27 Billion | -20.56 Billion | -16.26 Billion | -2.2 Billion | -13.62 Billion | -4.24 Billion |
| Debt repayment | -2.48 Billion | -2.87 Billion | -2.44 Billion | -2.31 Billion | -3.46 Billion | -366 Million |
| Dividends payments | -7.74 Billion | -7.75 Billion | -7.38 Billion | -7.41 Billion | -6.81 Billion | -6.96 Billion |
| Common Stock Repurchased | -8.71 Billion | -10.65 Billion | -3.05 Billion | -2.84 Billion | -5.53 Billion | -2.03 Billion |
| Common Stock Issuance | 3.98 Billion | 411 Million | 53.11 Million | 10.08 Billion | 1.96 Billion | 5.23 Billion |
| Other Financing Activities | 192 Million | 55 Million | -3.39 Billion | -149 Million | 50 Million | -113 Million |
| Accounts receivables | -1.5 Billion | -589 Million | -389 Million | 137 Million | -980 Million | -569 Million |
| Accounts payables | 479 Million | -48 Million | -21 Million | -324 Million | 553 Million | 309 Million |
| Inventory | -546 Million | -830 Million | 81 Million | -543 Million | -382 Million | -533 Million |
| Other working capital | 1.2 Billion | 464 Million | 570 Million | 439 Million | 1 Billion | 1.29 Billion |
| Cash at beginning of period | 7.51 Billion | 12.4 Billion | 9.65 Billion | 11.11 Billion | 13.27 Billion | 8.86 Billion |
| Cash at end of period | 13.39 Billion | 7.51 Billion | 12.4 Billion | 9.65 Billion | 11.11 Billion | 13.27 Billion |
| Capital Expenditure | -2.75 Billion | -2.67 Billion | -2.97 Billion | -2.58 Billion | -2.25 Billion | -3.35 Billion |
| Effect of forex changes on cash | 100 Million | -32 Million | -266 Million | 286 Million | 69 Million | -26 Million |
| Net cash flow / Change in cash | 5.87 Billion | -4.89 Billion | 2.74 Billion | -1.45 Billion | -2.15 Billion | 4.41 Billion |
| Free Cash Flow | 11.7 Billion | 11.56 Billion | 12.1 Billion | 11.06 Billion | 11.36 Billion | 10.91 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.18 Billion | 3.26 Billion | 2.6 Billion | 8.57 Billion | 2.63 Billion | 1.51 Billion |
| Depreciation & Amortization | 1.96 Billion | 1.16 Billion | 1.27 Billion | 8.27 Billion | 1.58 Billion | 3.11 Billion |
| Deferred income taxes | 200 Million | 595 Million | 441 Million | 551 Million | -261 Million | 39 Million |
| Stock-based compensation | 255 Million | 257 Million | 260 Million | 865 Million | 248 Million | 205 Million |
| Change in working capital | 1.04 Billion | -89.17 Million | -2.26 Billion | -369 Million | -384 Million | 1.17 Billion |
| Other non-cash items | -359 Million | 3.53 Billion | 4.53 Billion | -3.43 Billion | -1.28 Billion | -668 Million |
| Investing Cash Flow | -374 Million | -3.18 Billion | -871.32 Million | 5.59 Billion | -1.76 Billion | -2.21 Billion |
| Investments in PPE | -799 Million | -740.08 Million | -1.12 Billion | -2.75 Billion | -783 Million | -683 Million |
| Acquisitions | -63 Million | -3.25 Billion | -269.44 Million | -3.56 Billion | -11 Million | -3.44 Billion |
| Investment purchases | -1.01 Billion | -279.9 Million | -48.46 Million | -747 Million | -573 Million | -39 Million |
| Sales/Maturities of investments | 1.47 Billion | 1.06 Billion | 566.99 Million | 11.59 Billion | 179 Million | 290 Million |
| Other Investing Activities | -453 Million | 19.79 Million | -431 Million | 1.06 Billion | -572 Million | 1.66 Billion |
| Financing Cash Flow | -382 Million | -3.25 Billion | -5 Billion | -14.27 Billion | -607 Million | -832 Million |
| Debt repayment | -2.51 Billion | -903.45 Million | -1.18 Billion | -2.48 Billion | -64 Million | -2.7 Billion |
| Dividends payments | -85.29 Million | -2.48 Billion | -5.04 Billion | -7.74 Billion | -57.57 Million | -53.24 Million |
| Common Stock Repurchased | -2.85 Billion | -1.61 Billion | -1.06 Billion | -8.71 Billion | -1.25 Billion | -1.62 Billion |
| Common Stock Issuance | 4.91 Million | 24.73 Million | - | 3.98 Billion | -6.59 Million | -2.15 Million |
| Other Financing Activities | -38 Million | -24.92 Million | -10.66 Million | 192 Million | 772.16 Million | 3.55 Billion |
| Accounts receivables | 328 Million | -511.43 Million | -891.68 Million | -1.5 Billion | -240 Million | -117 Million |
| Accounts payables | -109 Million | -147.48 Million | -396.41 Million | 479 Million | 564 Million | -184 Million |
| Inventory | 90 Million | -19.99 Million | -124.05 Million | -546 Million | 33 Million | -33 Million |
| Other working capital | 731 Million | 589.72 Million | -848.06 Million | 1.2 Billion | -741 Million | 1.51 Billion |
| Cash at beginning of period | 7.9 Billion | 9.45 Billion | 13.38 Billion | 7.51 Billion | 12.4 Billion | 10.88 Billion |
| Cash at end of period | 13.6 Billion | 7.89 Billion | 9.45 Billion | 13.39 Billion | 13.39 Billion | 12.4 Billion |
| Capital Expenditure | -799 Million | -740.08 Million | -1.12 Billion | -2.75 Billion | -783 Million | -683 Million |
| Effect of forex changes on cash | 176 Million | -34 Million | -126 Million | 100 Million | 160 Million | -166 Million |
| Net cash flow / Change in cash | 5.7 Billion | -1.55 Billion | -3.93 Billion | 5.87 Billion | 988 Million | 1.52 Billion |
| Free Cash Flow | 5.48 Billion | 4.12 Billion | 1.07 Billion | 11.7 Billion | 1.76 Billion | 4.69 Billion |
MANALIPETC
8621
1471
8111
0HYA
INNOVTEC